SCHEMBL22378564

SCHEMBL22378564

N#Cc1cc(-n2c3ccccc3c3ccccc32)ccc1-c1cccc(-c2ccccc2-n2c3ccccc3c3cccc(C#N)c32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
GABRG2 P18507 7/20 0.34
GABRB3 P28472 7/20 0.34
GABRA1 P14867 6/20 0.34
GABRA5 P31644 5/20 0.34
GABRA3 P34903 5/20 0.34
GABRA2 P47869 4/20 0.34
HIF1A Q16665 1/20 0.34
CYP19A1 P11511 1/20 0.34
TRPA1 O75762 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22378517 0.98 NR3C1 (0.36) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22377546 0.94 NR3C1 (0.38) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22378368 0.93 SMN1; SMN2 (0.40) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22378634 0.93 NR3C1 (0.35) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22377937 0.93 NR3C1 (0.35) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22378811 0.92 GABRA1 (0.37) NR3C1SMN1; SMN2ALDH1A1HPGDMAPK1
SCHEMBL22377778 0.92 NR3C1 (0.36) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22379385 0.91 NR3C1 (0.39) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22378485 0.91 NR3C1 (0.37) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22378502 0.91 KDM4E (0.34) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 NR3C1 1012/4885SMN1; SMN2 3839/4885ALDH1A1 19/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 NR3C1 1012/4885SMN1; SMN2 3839/4885ALDH1A1 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.